Information for this Review was obtained by a search of PubMed using the search terms “pancreas metastasis”, “pancreas metastasectomy”, “pancreas resection metastasis” and “pancreas resection non-pancreatic primary cancer”. We selected studies published in any language with at least five patients who underwent pancreatic metastasectomy. Only articles published before September, 2008, were included.
ReviewThe role of surgery in the management of isolated metastases to the pancreas
Introduction
Metastatic disease to the pancreas is uncommon and accounts for less than 2% of all pancreatic malignancies. Most patients with metastatic disease are not candidates for resection since they have widespread systemic disease at the time of diagnosis. Although isolated pancreatic metastases are rare, high volume pancreatic surgery centres will see patients with metastatic disease that is amenable to resection. Moreover, the relatively favourable biology of some cancers that often metastasise to the pancreas, such as renal-cell cancer (figure), makes the recognition of surgically resectable disease important. For these patients, the role of pancreatic metastasectomy is not well defined.
So far, no prospective or case-controlled trials have compared the efficacy of pancreatic metastasectomy with non-operative management. Because of the uncommon presentation of isolated pancreatic metastasis and the tendency to resect these lesions, it is unlikely that such a study will be done. Therefore, the usefulness of pancreatic metastasectomy will be assessed by long-term survival in retrospective analyses. The largest study of pancreatic metastasectomy includes only 49 patients,4 and others include from 16 to 29 patients.5, 6, 7, 8 All have found that long-term survival can be achieved with pancreatic metastasectomy (table 1).4, 5, 6, 7, 8 Additionally, many case reports and results from smaller cohorts of patients undergoing pancreatic metastasectomy support the notion that the procedure improves survival in patients with isolated metastases to the pancreas.9, 10, 11
This Review aims to assess literature on pancreatic metastasectomy to provide guidelines for the surgical management of metastases to the pancreas. We review all studies with at least five patients who underwent pancreatic metastasectomy. Studies are retrospective single-institutional analyses and include a total of 243 patients. The breakdown of pathological diagnoses in this combined cohort is shown in table 2. An aggregate analysis was done on this cohort and is included in some parts of this Review. Findings from the aggregate analysis are designated as a pooled or aggregate result in the text in order to distinguish them from results listed in individual reports. Survival was analysed using Kaplan-Meier methods. Cox proportional hazard analysis was used to estimate relative differences between groups. Statistical significance was accepted at a p value less than 0·05. STATA statistical software (version 9.0SE, College Station, TX) was used for all statistical analyses. Three questions regarding pancreatic metastasectomy are addressed: How do patients with isolated pancreatic metastases typically present? Is pancreatic metastasectomy safe? Is pancreatic metastasectomy effective? Finally, we provide recommendations for selecting patients that might benefit from pancreatic metastasectomy.
Section snippets
How do patients with isolated pancreatic metastases typically present?
As with primary pancreatic cancer, early signs and symptoms of isolated pancreatic metastases are often non-specific and subtle. Isolated pancreatic metastases are often found with routine surveillance imaging for primary lesions or as an incidental finding on imaging done for an unrelated indication. The characteristic appearance of metastases to the pancreas on cross sectional-imaging has been described. Unlike pancreatic adenocarcinoma, secondary pancreatic cancers most often enhance on
Is pancreatic metastasectomy safe?
Pancreatic resection has been associated with a high rate of mortality and morbidity, and even the resection of localised primary pancreatic cancer has been questioned. However, many recent reports confirm that the mortality associated with pancreatic resection has declined over the past three decades. We previously reported a perioperative mortality rate of 2% and morbidity rate of 38% for patients undergoing pancreaticoduodenectomy for primary pancreatic pathology.25 These figures are similar
Is pancreatic metastasectomy effective?
The effectiveness of pancreatic metastasectomy is dependent on the tumour biology of the primary cancer. In most large studies, the best predictor for long-term survival is cancer type.4, 5, 7 Table 4 shows the distribution of cancers and associated survivals for the analysis of pooled data. Renal-cell carcinoma is associated with the best outcome, whereas lung cancer predicts the worst outcome. 80% of pancreatic metastasectomies result from four cancer-types: renal-cell cancer, colorectal
Selection of patients for pancreatic metastasectomy
Because of the possibility of substantial morbidity after pancreatic resection and the questionable benefit of metastasectomy in some patients, pancreatic metastasectomy should be offered only after a thoughtful and systematic selection process. Ideally, this process would involve a multidisciplinary team that includes a medical oncologist and an experienced pancreatic surgeon. Once the decision is made to proceed with resection, evidence suggests that the procedure should be done at a high
Conclusion
Although localised metastases to the pancreas are rare, pancreatic surgery referral centres will encounter these patients. Many case reports and small studies describe favourable outcomes for pancreatic metastasectomy. Renal-cell cancer, colorectal cancer, melanoma, and sarcoma are the most commonly resected metastases to the pancreas. The best outcome for pancreatic metastasectomy among these cancers is for renal-cell cancer. However, patients in all four groups might benefit from the
Search strategy and selection criteria
References (59)
Survival after liver resection for secondary tumors
Am J Surg
(1978)- et al.
Metastasis to the pancreas: characterization by morphology and contrast enhancement features on CT and MRI
Pancreatology
(2008) - et al.
Renal cell carcinoma metastatic to the pancreas: clinical and radiological features
Mayo Clin Proc
(2000) - et al.
Renal cell carcinoma metastatic to the pancreas: results of surgical management
J Gastrointest Surg
(2001) - et al.
Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival
J Urol
(2001) - et al.
Renal cell carcinoma metastatic to the pancreas: a single–institution series and review of the literature
Urology
(2000) - et al.
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome
J Urol
(2001) - et al.
Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma
Urology
(2009) - et al.
Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers
J Urol
(2008) - et al.
Pulmonary resection of metastatic renal cell carcinoma
Ann Thorac Surg
(1994)
Long-term results after pulmonary resection of renal cell carcinoma metastases
Ann Thorac Surg
Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
Ann Thorac Surg
Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?
Ann Thorac Surg
Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients
Ann Thorac Surg
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease
J Am Coll Surg
Complete metastasectomy in patients with stage IV metastatic melanoma
Lancet Oncol
Gastrointestinal metastases from malignant melanoma
Surg Oncol
Lung resection for colorectal metastases. 10-year results
Arch Surg
Treatment outcomes of hepatic and pulmonary metastases from colorectal carcinoma
J Gastroenterol Hepatol
Pancreatic resection of isolated metastases from non-pancreatic primary cancers
Ann Surg Oncol
Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection
World J Surg Oncol
Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?
Ann Surg Oncol
Metastatic lesions to the pancreas. When is resection reasonable?
Chirurg
Results after pancreatic resection for metastatic lesions
Ann Surg Oncol
Resection of pancreatic metastasis from renal cell carcinoma and an early gastric cancer
J Nippon Med Sch
An unusual indication for central pancreatectomy–late pancreatic metastasis of ocular malignant melanoma
Chirurgia (Bucur)
Surgical treatment for isolated multiple pancreatic metastases from renal cell carcinoma: report of a case
J Nippon Med Sch
Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature
Pancreas
Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome
Ann Surg Oncol
Cited by (184)
Pancreatic metastasis with obstructive jaundice: A rare recurrence pattern of breast cancer after a 10-year interval
2023, Asian Journal of SurgeryPancreatic metastasis from sarcoma, an infrequent finding
2023, Gastroenterologia y Hepatologia